http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015135306-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af0be3df8981d0b87aca182e023b652d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-542
filingDate 2014-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea6ffcfe2d13eb2ef106e93657256286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ba30eadffeb74fb3164dcc3005d77c
publicationDate 2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015135306-A1
titleOfInvention Uses of artemisinin and derivatives thereof in manufacture of medicaments for prevention and treatment of vascular diseases in ophthalmology and pharmaceutical compositions
abstract Disclosed are uses of artemisinin and derivatives thereof in the manufacture of medicaments for inhibition of ocular vascular endothelial cell proliferation, or the prevention and treatment of related diseases of ocular vascular system exudation, edema, new blood vessels formation and proliferation, and pharmaceutical compositions comprising artemisinin and derivatives thereof. Artemisinin and derivatives thereof of the present invention can be used for the prevention and treatment of ocular vascular related diseases, such as age-related macular degeneration, diabetic retinopathy, retinal central vein occlusion and retinal branch vein occlusion etc.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018025083-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3493811-A4
priorityDate 2014-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9838675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442226

Total number of triples: 28.